NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Current Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2013 | - |
Mar2012 | - |
How is Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2013 | - | 0 | |
Mar2012 | - | - |
Compare Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹392.7 Cr | 1.5% | 9.3% | -0.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,657.2 Cr | -2.5% | 0.1% | 17.5% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,685.8 Cr | -7.2% | -2.8% | 41% | Stock Analytics | |
VENKYS (INDIA) | ₹2,285.5 Cr | -1.3% | -0.5% | -13.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,475.9 Cr | -0.8% | -2.7% | -29.7% | Stock Analytics | |
INDO US BIOTECH | ₹302.3 Cr | -10.2% | -0.5% | -28% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 1.5% |
9.3% |
-0.2% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses